Field Therapy for Actinic Keratosis: One Nurse Practitioner's Perspective on Evolving Approaches and Patient-centered Care.

BACKGROUND

Actinic keratosis (AK) is a common dermatologic condition that can progress to squamous cell carcinoma if left untreated. Field therapy plays a critical role in managing both visible and subclinical lesions within sun-damaged skin.

OBJECTIVE

The author sought to provide one nurse practitioner's perspective on the evolving role of field therapy in AK management, emphasizing patient-centered care, real-world challenges for all advanced practice providers (APPs), and personal experience.

METHODS

This commentary reflects clinical observations, patient interactions, and the author's own experience undergoing multiple field therapies, including topical 5-fluorouracil, imiquimod, tirbanibulin, and photodynamic therapy. Emphasis is placed on treatment selection, education, and adherence strategies.

RESULTS

Field therapy is effective when personalized to the patient's lifestyle, skin type, and preferences. Empathetic counseling and tailored treatment regimens improve outcomes and satisfaction. Newer therapies such as tirbanibulin and daylight photodynamic therapy offer promising options with improved tolerability.

CONCLUSION

APPs are uniquely positioned to lead in early AK treatment and prevention. Combining clinical expertise with patient education and empathy enhances the impact of field therapy. The author's dual perspective as a provider and patient offers valuable insight into the real-world application of evidence-based dermatologic care.